Plasmodium knowlesi Adapts In Vitro to Infect Duffy-Negative Erythrocytes

The Expanding Reach of Zoonotic Malaria

Plasmodium knowlesi, a parasite traditionally found in long-tailed macaques, has emerged as a significant cause of human malaria across Southeast Asia [1]. For decades, clinical susceptibility to this species and its close relative, Plasmodium vivax, was believed to be restricted to individuals expressing the Duffy-Antigen Receptor for Chemokine on their red blood cells [2, 3]. This genetic requirement has historically protected Duffy-negative populations, particularly those of African descent, from clinical infection [4, 5]. However, as other human malaria species face elimination, the rising incidence of P. knowlesi suggests an increasing capacity for this zoonotic pathogen to cross host species barriers [6, 7]. A recent study offers fresh insights into the molecular mechanisms that allow this parasite to overcome established host resistance factors, raising concerns about its potential to spread into new, previously protected patient populations.

Bypassing the Duffy-Antigen Barrier

The study demonstrates that Plasmodium knowlesi possesses greater invasion plasticity (the inherent capacity to utilize alternative molecular pathways to enter host red blood cells when primary receptors are unavailable) than previously recognized. While clinicians have long viewed the Duffy-Antigen Receptor for Chemokine as an absolute requirement for infection, the researchers successfully induced an adaptation in a controlled laboratory environment that allowed the parasite to bypass the need for this receptor. Through this experimental evolution, the Plasmodium knowlesi line successfully invaded and replicated in Duffy-negative erythrocytes, which are red blood cells lacking the standard surface protein typically required for parasite entry. This finding challenges the established clinical assumption that Duffy-negative status provides complete protection against this zoonotic species.

The researchers observed that this adaptation to Duffy-negative erythrocytes is stable and functions entirely independent of binding to the Duffy-Antigen Receptor for Chemokine. To confirm this independence, the authors exposed the adapted parasites to alpha-DARC antibodies, which are proteins designed to block the standard Duffy receptor site. The adapted parasite line resisted inhibition by alpha-DARC antibodies, maintaining its ability to infect cells even when the traditional entry point was chemically obstructed. Because the adapted parasite line can be maintained in Duffy-negative erythrocytes over multiple cycles, the pathogen appears capable of establishing a self-sustaining infection in populations previously considered non-susceptible. For practicing physicians, this shift in host-cell specificity indicates that the geographic and demographic range of Plasmodium knowlesi may be far broader than current epidemiological models suggest, necessitating a higher index of suspicion for malaria in patients returning from endemic regions regardless of their Duffy antigen status.

The Molecular Mechanism of Adaptation

To identify the genetic basis for this shift in host specificity, the researchers conducted a detailed genomic analysis of the adapted parasite lines. This investigation identified a genomic recombination event between the parasite's dbpα and dbpγ genes, which are members of the Duffy binding protein family typically involved in erythrocyte recognition. This recombination event (the exchange of genetic material between two distinct loci) resulted in the formation of a new chimeric gene called dbpαγ. This hybrid sequence, formed from the fusion of the two different parent genes, creates a protein product with altered binding properties that differ from the original wild-type proteins.

The researchers then sought to confirm whether this specific genetic change was responsible for the ability to infect Duffy-negative cells. They employed CRISPR-Cas9 targeted reversion, a precise gene-editing technique used to flip a specific sequence back to its original state, to manipulate the parasite's genome. By reverting the chimeric sequence back to its ancestral form, the authors demonstrated that dbpαγ is essential for the invasion of Fy- erythrocytes (red blood cells lacking the Duffy-antigen receptor). Without this specific chimeric gene, the parasite lost its capacity to replicate within Duffy-negative blood, confirming that this single genomic rearrangement serves as the molecular driver for the observed adaptation. This finding provides a clear mechanistic explanation for how Plasmodium knowlesi might overcome genetic resistance in human populations where Duffy-negative phenotypes predominate, potentially complicating future efforts to develop targeted antimalarial therapies.

Clinical Implications and Global Risk

The ability of Plasmodium knowlesi to adapt to Duffy-negative erythrocytes in a laboratory setting carries significant implications for global health security and the clinical management of zoonotic infections. While susceptibility to this parasite was previously thought to be restricted to Duffy-positive individuals, the discovery of a stable, DARC-independent invasion mechanism suggests that Plasmodium knowlesi possesses the potential to spread beyond Southeast Asia into geographic regions where the Duffy-negative phenotype is predominant. This finding is particularly relevant for public health in sub-Saharan Africa, where the Duffy-Antigen Receptor for Chemokine is largely absent in the population. As Plasmodium knowlesi incidence continues to rise in Malaysia and southern Thailand even as other human malaria species approach elimination, the capacity for this parasite to bypass traditional genetic resistance barriers could facilitate its establishment in new ecological niches.

Furthermore, these findings provide critical insights into the complex host-cell specificity and atypical invasion pathways observed in Plasmodium vivax, a closely related species that also relies on the Duffy-Antigen Receptor for Chemokine for erythrocyte entry. Clinicians have historically viewed Duffy-negative status as a form of complete protection against Plasmodium vivax, yet reports of infections in Duffy-negative individuals have challenged this assumption. The identification of the chimeric dbpαγ gene in Plasmodium knowlesi offers a molecular model for how related parasites may utilize genomic recombination to overcome host-cell restrictions. By demonstrating that a single genetic rearrangement can enable the bypass of the Duffy receptor, the study clarifies the mechanisms behind the invasion plasticity seen in other Plasmodium species. For practicing physicians, this emphasizes the need for vigilant diagnostic monitoring and broadens the differential diagnosis for febrile illnesses in populations previously considered non-susceptible to these zoonotic and human malaria strains.

References

1. Ramasamy R. Zoonotic Malaria – Global Overview and Research and Policy Needs. Frontiers in Public Health. 2014. doi:10.3389/fpubh.2014.00123

2. Miller LH, Mason SJ, Clyde DF, McGinniss MH. The Resistance Factor toPlasmodium vivaxin Blacks. New England Journal of Medicine. 1976. doi:10.1056/nejm197608052950602

3. Miller LH, Mason SJ, Dvorak JA, McGinniss MH, Rothman I. Erythrocyte Receptors for ( Plasmodium Knowlesi ) Malaria: Duffy Blood Group Determinants. Science. 1975. doi:10.1126/science.1145213

4. Horuk R, Chitnis CE, Darbonne WC, et al. A Receptor for the Malarial Parasite Plasmodium vivax : the Erythrocyte Chemokine Receptor. Science. 1993. doi:10.1126/science.7689250

5. Howes RE, Patil AP, Piel FB, et al. The global distribution of the Duffy blood group. Nature Communications. 2011. doi:10.1038/ncomms1265

6. Zinga M, Ibrahim A, Mohring F, et al. Plasmodium knowlesi can adapt to infect Duffy-negative Erythrocytes.. Blood. 2026. doi:10.1182/blood.2025029557

7. Muh F, Kim N, Nyunt MH, et al. Cross-species reactivity of antibodies against Plasmodium vivax blood-stage antigens to Plasmodium knowlesi. PLoS neglected tropical diseases. 2020. doi:10.1371/journal.pntd.0008323